Anthony
Clinical Development
AstraZeneca
Belgium
Biography
Anthony Johnson is Vice President, Early Clinical Development at AstraZeneca’s world-leading IMED Biotech Unit. Anthony joined AstraZeneca in 2014, holding a wealth of experience in exploratory clinical development across the pharmaceutical industry and academia. In his role he has recruited world- leading MD.PhDs and significantly improved both translational clinical science and operations, such as clinical trial cycle times. He oversees the iDecide program including REACT which focuses on real time visualisation and analysis of clinical trial data, while incorporating patient perspectives. REACT allows AstraZeneca to improve clinical trial design and ultimately enables patients to receive medicines more quickly.
Research Interest
Clinical Development
